ESR1 and breast carcinoma: However, NAR exerted an anti-proliferative and anti-estrogenic effect in ERα-expressing cancer cells, such as hepatoma HepG2 cells, cervix epithelioid carcinoma Hela cells, colon adenocarcinoma DLD-1 cells, and breast cancer MCF-7 cells [59].